Artículos de revistas sobre el tema "Thrombin-Inhibitory Activity"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Thrombin-Inhibitory Activity".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Bijak, M., R. Ziewiecki, J. Saluk, M. Ponczek, I. Pawlaczyk, H. Krotkiewski, B. Wachowicz y P. Nowak. "Thrombin inhibitory activity of some polyphenolic compounds". Medicinal Chemistry Research 23, n.º 5 (16 de octubre de 2013): 2324–37. http://dx.doi.org/10.1007/s00044-013-0829-4.
Texto completoWang, Xiaoyan, Zhen Yang, Feifei Su, Jin Li, Evans Owusu Boadi, Yan-xu Chang y Hui Wang. "Study on Structure Activity Relationship of Natural Flavonoids against Thrombin by Molecular Docking Virtual Screening Combined with Activity Evaluation In Vitro". Molecules 25, n.º 2 (20 de enero de 2020): 422. http://dx.doi.org/10.3390/molecules25020422.
Texto completoKINOSHITA, Akemi y Noboru HORIE. "Inhibitory Activity of Green Tea Catechins on Thrombin". Japanese Journal of Thrombosis and Hemostasis 4, n.º 6 (1993): 417–22. http://dx.doi.org/10.2491/jjsth.4.417.
Texto completoŽula, Aleš, Izabela Będziak, Danijel Kikelj y Janez Ilaš. "Synthesis and Evaluation of Spumigin Analogues Library with Thrombin Inhibitory Activity". Marine Drugs 16, n.º 11 (27 de octubre de 2018): 413. http://dx.doi.org/10.3390/md16110413.
Texto completoPanda, Subhamay y Iman Ehsan. "MOLECULAR DOCKING STUDIES OF SNAKE VENOM SERINE PROTEASE OF SHARP-NOSED PIT VIPER WITH HESPERETIN". Asian Journal of Pharmaceutical and Clinical Research 11, n.º 6 (7 de junio de 2018): 457. http://dx.doi.org/10.22159/ajpcr.2018.v11i6.25531.
Texto completoohishi, Rika, Naoko watanabe, Masaharu Aritomi, Komakazu Gomi, Takao Kiyota, Shuji Yamamoto, Torao lshida y Ikuro Maruyama. "Evidence that the Protein C Activation Pathway Amplifies the lnhibition of Thrombin Generation by Recombinant Human Thrombomodulin in Plasma". Thrombosis and Haemostasis 70, n.º 03 (1993): 423–26. http://dx.doi.org/10.1055/s-0038-1649598.
Texto completoDanihelová, Martina, Miroslav Veverka y Ernest Šturdík. "Inhibition of pathophysiological proteases with novel quercetin derivatives". Acta Chimica Slovaca 6, n.º 1 (1 de abril de 2013): 115–22. http://dx.doi.org/10.2478/acs-2013-0018.
Texto completoGerotziafas, Grigorios T., Galea Vasso, Jeanine M. Walenga, Evi Kalodiki, Mourad Chaari, Hatmi Mohamed, Jawed Fareed y Elalamy Ismail. "Thrombin Generation Assessment in Platelet Rich Plasma Offers Additional Criteria for Low Molecular Weight Heparin Antithrombotic Fingerprint Characterization." Blood 114, n.º 22 (20 de noviembre de 2009): 4177. http://dx.doi.org/10.1182/blood.v114.22.4177.4177.
Texto completoKang, Kyu-Tae, Byoung-In Jung, Ok-Nam Bae, Moo-Yeol Lee, Seung-Min Chung, Joo-Young Lee, Sang-Koo Lee, In-Chul Kim y Jin-Ho Chung. "Antithrombotic activity of LB30057, a newly synthesized direct thrombin inhibitor". Thrombosis and Haemostasis 89, n.º 01 (2003): 104–11. http://dx.doi.org/10.1055/s-0037-1613549.
Texto completoMaclean, Glenn, Stephanie Brister y Michael Buchanan. "Selective and Sustained Inhibition of Surface-bound Thrombin Activity by Intimatan/Heparin Cofactor II and Its Relevance to Assessing Systemic Anticoagulation In Vivo, Ex Vivo and In Vitro". Thrombosis and Haemostasis 86, n.º 09 (2001): 909–13. http://dx.doi.org/10.1055/s-0037-1616149.
Texto completoRömisch, Jürgen, Hans-Arnold Stöhr, Harald Stauß, Rainer Koschinsky, Werner Stüber y Eric-Paul Pâques. "Inhibition of In Vitro Clot Growth by r-Hirudin Is More Effective and Longer Sustained than by an Analogous Peptide". Thrombosis and Haemostasis 71, n.º 03 (1994): 320–24. http://dx.doi.org/10.1055/s-0038-1642437.
Texto completoClayton, Daniel, Sameer S. Kulkarni, Jessica Sayers, Luke J. Dowman, Jorge Ripoll-Rozada, Pedro José Barbosa Pereira y Richard J. Payne. "Chemical synthesis of a haemathrin sulfoprotein library reveals enhanced thrombin inhibition following tyrosine sulfation". RSC Chemical Biology 1, n.º 5 (2020): 379–84. http://dx.doi.org/10.1039/d0cb00146e.
Texto completoSwedenborg, Jesper, Maciej Dryjski, Siw Frebelius y Per Olsson. "Uptake and Inactivation of Thrombin on Rabbit Aortic Endothelium Studied with Two Different Substrates". Thrombosis and Haemostasis 54, n.º 04 (1985): 828–32. http://dx.doi.org/10.1055/s-0038-1660142.
Texto completoLongstaff, Colin, Man-Yu Wong y Patrick J. Gaffney. "An International Collaborative Study to Investigate Standardisation of Hirudin Potency". Thrombosis and Haemostasis 69, n.º 05 (1993): 430–35. http://dx.doi.org/10.1055/s-0038-1651628.
Texto completoGlusa, Erika, Ellen Bretschneider, Joachim Daum y Christiane Noeske-Jungblut. "Inhibition of Thrombin-mediated Cellular Effects by Triabin, a Highly Potent Anion-binding Exosite Thrombin Inhibitor". Thrombosis and Haemostasis 77, n.º 06 (1997): 1196–200. http://dx.doi.org/10.1055/s-0038-1656137.
Texto completoLindhout, Theo, Ron Blezer y H. Coenraad Hemker. "The Anticoagulant Mechanism of Action of Recombinant Hirudin (CGP 39393) in Plasma". Thrombosis and Haemostasis 64, n.º 03 (1990): 464–68. http://dx.doi.org/10.1055/s-0038-1647337.
Texto completoJUšKA, Alfonsas y Richard W. FARNDALE. "Inhibition of human platelet adenylate cyclase activity by adrenaline, thrombin and collagen: analysis and reinterpretation of experimental data". Biochemical Journal 340, n.º 1 (10 de mayo de 1999): 245–53. http://dx.doi.org/10.1042/bj3400245.
Texto completoTaira, Kenichi, Koichi Abe, Takayuki Ishibasi, Katsuaki Sato y Kazunori Ikebukuro. "Control of Aptamer Function Using Radiofrequency Magnetic Field". Journal of Nucleic Acids 2011 (2011): 1–6. http://dx.doi.org/10.4061/2011/103872.
Texto completoGABAZZA, Esteban C., Tatsuya HAYASHI, Masaru IDO, Yukihiko ADACHI y Koji SUZUKI. "Adenosine inhibits thrombin-induced expression of tissue factor on endothelial cells by a nitric oxide-mediated mechanism". Clinical Science 102, n.º 2 (3 de enero de 2002): 167–75. http://dx.doi.org/10.1042/cs1020167.
Texto completoBerry, Christopher N., Christine Girardot, Catherine Lecoffreo y Catherine Lunven. "Effects of the Synthetic Thrombin Inhibitor Argatroban on Fibrin- or Clot-Incorporated Thrombin: Comparison with Heparin and Recombinant Hirudin". Thrombosis and Haemostasis 72, n.º 03 (1994): 381–86. http://dx.doi.org/10.1055/s-0038-1648875.
Texto completoHouslay, M. D., D. Bojanic, D. Gawler, S. O'Hagan y A. Wilson. "Thrombin, unlike vasopressin, appears to stimulate two distinct guanine nucleotide regulatory proteins in human platelets". Biochemical Journal 238, n.º 1 (15 de agosto de 1986): 109–13. http://dx.doi.org/10.1042/bj2380109.
Texto completoTripodi, A., A. Krachmalnicoff y P. M. Mannucci. "Characterization of an Abnormal Antithrombin (Milano 2) with Defective Thrombin Binding". Thrombosis and Haemostasis 56, n.º 03 (1986): 349–52. http://dx.doi.org/10.1055/s-0038-1661681.
Texto completoPahl, M. V., N. D. Vaziri, F. Oveisi, J. Wang y Y. Ding. "Antithrombin III inhibits mesangial cell proliferation." Journal of the American Society of Nephrology 7, n.º 10 (octubre de 1996): 2249–53. http://dx.doi.org/10.1681/asn.v7102249.
Texto completoKrošlák, Erik, Tibor Maliar, Mária Maliarová, Peter Nemeček, Peter Hozlár, Miroslav Ondrejovič, Michaela Havrlentová y Ján Kraic. "Antioxidant and protease-inhibitory potential of extracts from grains of oat". Open Chemistry 14, n.º 1 (1 de enero de 2016): 324–34. http://dx.doi.org/10.1515/chem-2016-0035.
Texto completoGao, Yuye, Xie-an Yu, Bing Wang, Guo Yin, Jue Wang, Tiejie Wang y Kaishun Bi. "Based on Multi-Activity Integrated Strategy to Screening, Characterization and Quantification of Bioactive Compounds from Red Wine". Molecules 26, n.º 21 (8 de noviembre de 2021): 6750. http://dx.doi.org/10.3390/molecules26216750.
Texto completoKovalishyn, Vasyl, Vsevolod Tanchuk, Iryna Kopernyk, Volodymyr Prokopenko y Larysa Metelytsia. "Prediction of Thrombin and Factor Xa Inhibitory Activity with Associative Neural Networks". Current Computer Aided-Drug Design 10, n.º 3 (2 de marzo de 2015): 259–65. http://dx.doi.org/10.2174/157340991003150302231419.
Texto completoWang, Min, Yuanyuan Wang, Jinfeng Wang, Minji Zou, Shen Liu, Tao Xu, Xin Cai, Chen Wu, Jiaxi Wang y Donggang Xu. "Construction and characterization of a novel staphylokinase variant with thrombin-inhibitory activity". Biotechnology Letters 31, n.º 12 (15 de agosto de 2009): 1923–27. http://dx.doi.org/10.1007/s10529-009-0094-2.
Texto completoRen, Weixin, Yujie Ren, Minghui Dong y Yonghong Gao. "Design, Synthesis, and Thrombin Inhibitory Activity Evaluation of Some Novel Benzimidazole Derivatives". Helvetica Chimica Acta 99, n.º 4 (abril de 2016): 325–32. http://dx.doi.org/10.1002/hlca.201500527.
Texto completoCateni, Francesca, Marina Zacchigna, Bojan Doljak, Marko Anderluh, Giuseppe Procida y Andrej Piltaver. "Bioactive Lipids Metabolites in Amanita Virosa". Natural Product Communications 7, n.º 11 (noviembre de 2012): 1934578X1200701. http://dx.doi.org/10.1177/1934578x1200701121.
Texto completoFarrell, David H., Rehana S. Lovely y Lynn K. Boshkov. "Inhibition of Thrombin Cleavage of Factor VIII by Fibrinogen γ’ Chain Carboxyl Terminus." Blood 106, n.º 11 (16 de noviembre de 2005): 1957. http://dx.doi.org/10.1182/blood.v106.11.1957.1957.
Texto completoBoross, Peter, Cafer Yildiz, Kamran Bakhtiari, Joost C. M. Meijers y C. Erik Hack. "Towards Restoring Coagulation in Hemophilia By Antibody-Mediated Inhibition of Antithrombin". Blood 126, n.º 23 (3 de diciembre de 2015): 550. http://dx.doi.org/10.1182/blood.v126.23.550.550.
Texto completoOno, Mayumi, Katsuhiko Nawa y Yasumasa Marumoto. "Antithrombotic Effects of Recombinant Human Soluble Thrombomodulin in a Rat Model of Vascular Shunt Thrombosis". Thrombosis and Haemostasis 72, n.º 03 (1994): 421–25. http://dx.doi.org/10.1055/s-0038-1648882.
Texto completoGerotziafas, Grigoris T., Marie-Paule Roman, Elisabeth Verdy, Mohamed Hatmi, Meyer M. Samama y Ismail Elalamy. "Platelets and Heparin Induced Thrombocytopenia Antibodies Do Not Influence the Inhibitory Activity of Argatroban on Thrombin Generation." Blood 110, n.º 11 (16 de noviembre de 2007): 929. http://dx.doi.org/10.1182/blood.v110.11.929.929.
Texto completoZavyalova, Elena, Valeriia Legatova, Rugiya Alieva, Arthur Zalevsky, Vadim Tashlitsky, Alexander Arutyunyan y Alexey Kopylov. "Putative Mechanisms Underlying High Inhibitory Activities of Bimodular DNA Aptamers to Thrombin". Biomolecules 9, n.º 2 (24 de enero de 2019): 41. http://dx.doi.org/10.3390/biom9020041.
Texto completoOkada, Chiaki, Noriyuki Hatae y Eiko Toyota. "Structural study of the Schiff base copper(II) chelates as thrombin inhibitor". Acta Crystallographica Section A Foundations and Advances 70, a1 (5 de agosto de 2014): C1665. http://dx.doi.org/10.1107/s205327331408334x.
Texto completoSassi, Mouna, Taher Chakroun, Elisabeth Mbemba, Patrick Van Dreden, Ismail Elalamy, Annette K. Larsen y Grigoris T. Gerotziafas. "The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1". Clinical and Applied Thrombosis/Hemostasis 23, n.º 2 (24 de septiembre de 2016): 155–63. http://dx.doi.org/10.1177/1076029616665922.
Texto completoMitchell, Christina A., Lena Hau y Hatem H. Salem. "Control of Thrombin Mediated Cleavage of Protein S". Thrombosis and Haemostasis 56, n.º 02 (1986): 151–54. http://dx.doi.org/10.1055/s-0038-1661630.
Texto completoOfosu, F. A., P. Sie, G. J. Modi, F. Fernandez, M. R. Buchanan, M. A. Blajchman, B. Boneu y J. Hirsh. "The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin". Biochemical Journal 243, n.º 2 (15 de abril de 1987): 579–88. http://dx.doi.org/10.1042/bj2430579.
Texto completoJandrot-Perrus, Martine, Marie-Geneviève Huisse, John L. Krstenansky, Annie Bezeaud y Marie-Claude Guillin. "Effect of the Hirudin Carboxy-Terminal Peptide 54-65 on the Interaction of Thrombin with Platelets". Thrombosis and Haemostasis 66, n.º 03 (1991): 300–305. http://dx.doi.org/10.1055/s-0038-1646411.
Texto completoHauptmann, J., B. Kaiser, G. Nowak, J. Stürzebecher y F. Markwardt. "Comparison of the Anticoagulant and Antithrombotic Effects of Synthetic Thrombin and Factor Xa Inhibitors". Thrombosis and Haemostasis 63, n.º 02 (1990): 220–23. http://dx.doi.org/10.1055/s-0038-1645198.
Texto completoTanratana, Pansakorn y John P. Sheehan. "Detection of Factor IXa Activity By the Enhanced Thrombin Generation Assay". Blood 124, n.º 21 (6 de diciembre de 2014): 4242. http://dx.doi.org/10.1182/blood.v124.21.4242.4242.
Texto completoTakeyama, Masahiro, Keiji Nogami, Tomoko Matsumoto, Tetsuhiro Soeda, Tsukasa Suzuki, Kunihiro Hattori y Midori Shima. "Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity". Thrombosis and Haemostasis 103, n.º 01 (2010): 94–102. http://dx.doi.org/10.1160/th09-05-0338.
Texto completoStern, D. M., I. Bank, P. P. Nawroth, J. Cassimeris, W. Kisiel, J. W. Fenton, C. Dinarello, L. Chess y E. A. Jaffe. "Self-regulation of procoagulant events on the endothelial cell surface." Journal of Experimental Medicine 162, n.º 4 (1 de octubre de 1985): 1223–35. http://dx.doi.org/10.1084/jem.162.4.1223.
Texto completoMisra, Raj N., Yolanda F. Kelly, Bärbel R. Brown, Daniel G. M. Roberts, Saeho Chong y Steven M. Seiler. "Argatroban analogs: Synthesis, thrombin inhibitory activity and cell permeability of aminoheterocyclic guanidine surrogates". Bioorganic & Medicinal Chemistry Letters 4, n.º 18 (septiembre de 1994): 2165–70. http://dx.doi.org/10.1016/s0960-894x(00)80064-5.
Texto completoForneris, Federico, B. Tom Burnley y Piet Gros. "Ensemble refinement shows conformational flexibility in crystal structures of human complement factor D". Acta Crystallographica Section D Biological Crystallography 70, n.º 3 (15 de febrero de 2014): 733–43. http://dx.doi.org/10.1107/s1399004713032549.
Texto completoStavenuiter, Fabian, Nicole Davis, Erning Duan, Andrew Gale y Mary Heeb. "Platelet protein S directly inhibits procoagulant activity on platelets and microparticles". Thrombosis and Haemostasis 109, n.º 02 (2013): 229–37. http://dx.doi.org/10.1160/th12-08-0622.
Texto completoTsoupras, Alexandros B., Maria Roulia, Eleftherios Ferentinos, Ioannis Stamatopoulos, Constantinos A. Demopoulos y Panayotis Kyritsis. "Structurally Diverse Metal Coordination Compounds, Bearing Imidodiphosphinate and Diphosphinoamine Ligands, as Potential Inhibitors of the Platelet Activating Factor". Bioinorganic Chemistry and Applications 2010 (2010): 1–8. http://dx.doi.org/10.1155/2010/731202.
Texto completoWutt, Daqing, Jiong Shen y Binggen Ru. "Expression and purification of human metallothionein-3 beta domain in e.coli". Protein & Peptide Letters 7, n.º 4 (agosto de 2000): 257–63. http://dx.doi.org/10.2174/092986650704221207123557.
Texto completoSugimoto, Emika, Minako Sata, Toshio Asano y Mitsunobu Mohri. "The Inhibitory Effect of Recombinant Human Soluble Thrombomodulin on Initiation and Extension of Coagulation". Thrombosis and Haemostasis 82, n.º 12 (1999): 1687–93. http://dx.doi.org/10.1055/s-0037-1614900.
Texto completoTang, Wenwen, Yuan Chen y Fengxia Guo. "Comparative Analysis of Roots from Vicatia thibetica de Boiss and Angelica sinensis Based on Chemical Composition, Antioxidant, Nitrite-Scavenging and Enzyme Inhibition Activities". Molecules 28, n.º 4 (17 de febrero de 2023): 1942. http://dx.doi.org/10.3390/molecules28041942.
Texto completo